Galectin Therapeutics Inc
GALTFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Galectin Therapeutics Inc Makes Money
No flow chart is shown because the available revenue and expense lines do not reconcile exactly. The reported financial history below remains available.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 17 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 30, 2026.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Galectin Therapeutics Inc's recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2026-01-05 · Jamil Khurram: Larger than 13 of the 14 other insider sales of Common stock on file. SEC filing
- 2025-11-18 · CALLICUTT JACK W: Larger than all 14 other insider sales of Common stock on file. SEC filing
Independent insiders buying near the same time
- 2025-07-17–2025-07-21: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2024-12-24–2024-12-30: 4 event(s) across 4 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing )
- 2024-10-16–2024-10-23: 3 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing )
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-29 | Jamil Khurram · Chief Medical Officer | Common Stock | S — Open market or private sale | −47,467 | 5.04 | SEC filing |
| 2026-06-29 | Shlevin Harold H. · Director | Common Stock | S — Open market or private sale | −22,268 | 5.04 | SEC filing |
| 2026-06-26 | Shlevin Harold H. · Director | Common Stock | S — Open market or private sale | −7,732 | 5.00 | SEC filing |
| 2026-06-26 | Jamil Khurram · Chief Medical Officer | Common Stock | S — Open market or private sale | −2,533 | 5.00 | SEC filing |
| 2026-06-26 | Jamil Khurram · Chief Medical Officer | Common Stock | S — Open market or private sale | −2,037 | 5.00 | SEC filing |
| 2026-06-23 | Jamil Khurram · Chief Medical Officer | Common Stock | S — Open market or private sale | −7,557 | 3.14 | SEC filing |
| 2026-05-26 | Jamil Khurram · Chief Medical Officer | Common Stock | S — Open market or private sale | −568 | 3.10 | SEC filing |
| 2026-02-06 | ELDRED KARY · Director | Common Stock | P — Open market or private purchase | +300 | 2.70 | SEC filing |
Showing 8 of 20 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-29 | Jamil Khurram · Chief Medical Officer | Common Stock | M — Exercise or conversion of derivative security | +47,467 | SEC filing |
| 2026-06-29 | Shlevin Harold H. · Director | Common Stock | M — Exercise or conversion of derivative security | +22,268 | SEC filing |
| 2026-06-29 | Shlevin Harold H. · Director | Stock Option (right to buy) | M — Exercise or conversion of derivative security | −22,268 | SEC filing |
| 2026-06-29 | Jamil Khurram · Chief Medical Officer | Stock Option (right to buy) | M — Exercise or conversion of derivative security | −47,467 | SEC filing |
| 2026-06-26 | Jamil Khurram · Chief Medical Officer | Stock Option (right to buy) | M — Exercise or conversion of derivative security | −2,533 | SEC filing |
| 2026-06-26 | Shlevin Harold H. · Director | Stock Option (right to buy) | M — Exercise or conversion of derivative security | −7,732 | SEC filing |
| 2026-06-26 | Jamil Khurram · Chief Medical Officer | Stock option (right to buy) | M — Exercise or conversion of derivative security | −2,037 | SEC filing |
| 2026-06-26 | Jamil Khurram · Chief Medical Officer | Common Stock | M — Exercise or conversion of derivative security | +2,037 | SEC filing |
Showing 8 of 27 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2025-11-24 | CZIRR JAMES C · 10% owner | Common Stock | J — Other acquisition or disposition | −24,000 | SEC filing |
| 2025-03-31 | CZIRR JAMES C · 10% owner | Common Stock | J — Other acquisition or disposition | +1,000 | SEC filing |
| 2024-09-30 | CZIRR JAMES C · 10% owner | Common Stock | J — Other acquisition or disposition | +1,000 | SEC filing |
| 2024-03-31 | CZIRR JAMES C · 10% owner | Common Stock | J — Other acquisition or disposition | +1,000 | SEC filing |
Showing 4 of 4 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.